Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,960 shares at $554.32 ($2.7M) on 2021-01-25, disclosed to the SEC on 2021-01-27.
Open-market sale of $2.7M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $554.32 | 2,480 | $1.4M | 50.0% |
| 2 | $554.32 | 2,480 | $1.4M | 50.0% |
| Total | $554.32 avg | 4,960 | $2.7M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |